The RNA-Binding Protein DDX1 Promotes Primary MicroRNA Maturation and Inhibits Ovarian Tumor Progression

Cell Reports

Volumn 8, Issue 5, 2014, Pages 1447-1460

  Han, Cecil ^a   Liu, Yunhua ^a   Wan, Guohui ^a   Choi, Hyun Jin ^a   Zhao, Luqing ^a   Ivan, Cristina ^a   He, Xiaoming ^b   Sood, Anil K ^a   Zhang, Xinna ^a   Lu, Xiongbin ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b The Ohio State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; MICRORNA; MICRORNA 200; PROTEIN DDX1; REGULATOR PROTEIN; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; DDX1 PROTEIN, HUMAN; DDX1 PROTEIN, MOUSE; DEAD BOX PROTEIN; TUMOR MARKER;

ARTICLE; BIOGENESIS; CANCER INHIBITION; CONTROLLED STUDY; DNA DAMAGE; FEMALE; GENE EXPRESSION; GENE INDUCTION; HUMAN; HUMAN CELL; METASTASIS; MICROPROCESSOR; MOUSE; MOUSE MODEL; NONHUMAN; OUTCOME ASSESSMENT; OVARY TUMOR; PROTEIN INDUCTION; RNA PROCESSING; TUMOR GROWTH; ADENOCARCINOMA; ANIMAL; C57BL MOUSE; GENETICS; HEK293 CELL LINE; METABOLISM; OVARIAN NEOPLASMS; TUMOR CELL LINE;

ADENOCARCINOMA; ANIMALS; CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; DNA DAMAGE; FEMALE; HEK293 CELLS; HUMANS; MICE; MICE, INBRED C57BL; MICRORNAS; OVARIAN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84922588965     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2014.07.058     Document Type: Article

References (50)

1. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
2. Bartkova J., Rezaei N., Liontos M., Karakaidos P., Kletsas D., Issaeva N., Vassiliou L.V., Kolettas E., Niforou K., Zoumpourlis V.C., et al. Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006, 444:633-637.
3. Braun C.J., Zhang X., Savelyeva I., Wolff S., Moll U.M., Schepeler T., Ørntoft T.F., Andersen C.L., Dobbelstein M. p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res. 2008, 68:10094-10104.
4. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K., et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 2002, 99:15524-15529.
5. Calin G.A., Sevignani C., Dumitru C.D., Hyslop T., Noch E., Yendamuri S., Shimizu M., Rattan S., Bullrich F., Negrini M., Croce C.M. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl. Acad. Sci. USA 2004, 101:2999-3004.
6. Calin G.A., Ferracin M., Cimmino A., Di Leva G., Shimizu M., Wojcik S.E., Iorio M.V., Visone R., Sever N.I., Fabbri M., et al. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N.Engl. J. Med. 2005, 353:1793-1801.
7. Chang C.J., Chao C.H., Xia W., Yang J.Y., Xiong Y., Li C.W., Yu W.H., Rehman S.K., Hsu J.L., Lee H.H., et al. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Nat. Cell Biol. 2011, 13:317-323.
8. Chong M.M., Zhang G., Cheloufi S., Neubert T.A., Hannon G.J., Littman D.R. Canonical and alternate functions of the microRNA biogenesis machinery. Genes Dev. 2010, 24:1951-1960.
9. Davalos V., Esteller M. MicroRNAs and cancer epigenetics: a macrorevolution. Curr. Opin. Oncol. 2010, 22:35-45.
10. Esteller M. Non-coding RNAs in human disease. Nat. Rev. Genet. 2011, 12:861-874.
11. Friedman R.C., Farh K.K., Burge C.B., Bartel D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009, 19:92-105.
12. Fuller-Pace F.V., Moore H.C. RNA helicases p68 and p72: multifunctional proteins with important implications for cancer development. Future Oncol. 2011, 7:239-251.
13. Gregory R.I., Yan K.P., Amuthan G., Chendrimada T., Doratotaj B., Cooch N., Shiekhattar R. The Microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240.
14. Gregory R.I., Chendrimada T.P., Shiekhattar R. MicroRNA biogenesis: isolation and characterization of the microprocessor complex. Methods Mol. Biol. 2006, 342:33-47.
15. Gregory P.A., Bert A.G., Paterson E.L., Barry S.C., Tsykin A., Farshid G., Vadas M.A., Khew-Goodall Y., Goodall G.J. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat. Cell Biol. 2008, 10:593-601.
16. Halazonetis T.D., Gorgoulis V.G., Bartek J. An oncogene-induced DNA damage model for cancer development. Science 2008, 319:1352-1355.
17. He L., He X., Lim L.P., de Stanchina E., Xuan Z., Liang Y., Xue W., Zender L., Magnus J., Ridzon D., et al. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
18. Iorio M.V., Croce C.M. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med. 2012, 4:143-159.
19. Ishii H., Saito T. Radiation-induced response of micro RNA expression in murine embryonic stem cells. Med. Chem. 2006, 2:555-563.
20. Kawahara Y., Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc. Natl. Acad. Sci. USA 2012, 109:3347-3352.
21. Kawai S., Amano A. BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex. J.Cell Biol. 2012, 197:201-208.
22. Kim T., Veronese A., Pichiorri F., Lee T.J., Jeon Y.J., Volinia S., Pineau P., Marchio A., Palatini J., Suh S.S., et al. p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J.Exp. Med. 2011, 208:875-883.
23. Korpal M., Kang Y. The emerging role of miR-200 family of microRNAs in epithelial-mesenchymal transition and cancer metastasis. RNA Biol. 2008, 5:115-119.
24. Korpal M., Lee E.S., Hu G., Kang Y. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J.Biol. Chem. 2008, 283:14910-14914.
25. Korpal M., Ell B.J., Buffa F.M., Ibrahim T., Blanco M.A., Celià-Terrassa T., Mercatali L., Khan Z., Goodarzi H., Hua Y., et al. Direct targeting of Sec23a by miR-200s influences cancer cell secretome and promotes metastatic colonization. Nat. Med. 2011, 17:1101-1108.
26. Lee Y.S., Dutta A. MicroRNAs in cancer. Annu. Rev. Pathol. 2009, 4:199-227.
27. Lee Y., Ahn C., Han J., Choi H., Kim J., Yim J., Lee J., Provost P., Rådmark O., Kim S., Kim V.N. The nuclear RNase III Drosha initiates microRNA processing. Nature 2003, 425:415-419.
28. Li L., Monckton E.A., Godbout R. A role for DEAD box 1 at DNA double-strand breaks. Mol. Cell. Biol. 2008, 28:6413-6425.
29. Lund E., Dahlberg J.E. Substrate selectivity of exportin 5 and Dicer in the biogenesis of microRNAs. Cold Spring Harb. Symp. Quant. Biol. 2006, 71:59-66.
30. Merritt W.M., Lin Y.G., Han L.Y., Kamat A.A., Spannuth W.A., Schmandt R., Urbauer D., Pennacchio L.A., Cheng J.F., Nick A.M., et al. Dicer, Drosha, and outcomes in patients with ovarian cancer. N.Engl. J. Med. 2008, 359:2641-2650.
31. Mori M., Triboulet R., Mohseni M., Schlegelmilch K., Shrestha K., Camargo F.D., Gregory R.I. Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer. Cell 2014, 156:893-906.
32. Murchison E.P., Hannon G.J. miRNAs on the move: miRNA biogenesis and the RNAi machinery. Curr. Opin. Cell Biol. 2004, 16:223-229.
33. Park S.M., Gaur A.B., Lengyel E., Peter M.E. The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev. 2008, 22:894-907.
34. Pecot C.V., Rupaimoole R., Yang D., Akbani R., Ivan C., Lu C., Wu S., Han H.D., Shah M.Y., Rodriguez-Aguayo C., et al. Tumour angiogenesis regulation by the miR-200 family. Nat. Commun. 2013, 4:2427.
35. Pothof J., Verkaik N.S., van IJcken W., Wiemer E.A., Ta V.T., van der Horst G.T., Jaspers N.G., van Gent D.C., Hoeijmakers J.H., Persengiev S.P. MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response. EMBO J. 2009, 28:2090-2099.
36. Raines R.T. Ribonuclease A. Chem. Rev. 1998, 98:1045-1066.
37. Roby K.F., Taylor C.C., Sweetwood J.P., Cheng Y., Pace J.L., Tawfik O., Persons D.L., Smith P.G., Terranova P.F. Development of a syngeneic mouse model for events related to ovarian cancer. Carcinogenesis 2000, 21:585-591.
38. Siomi H., Siomi M.C. Posttranscriptional regulation of microRNA biogenesis in animals. Mol. Cell 2010, 38:323-332.
39. Slezak-Prochazka I., Durmus S., Kroesen B.J., van den Berg A. MicroRNAs, macrocontrol: regulation of miRNA processing. RNA 2010, 16:1087-1095.
40. Suzuki H.I., Yamagata K., Sugimoto K., Iwamoto T., Kato S., Miyazono K. Modulation of microRNA processing by p53. Nature 2009, 460:529-533.
41. Trabucchi M., Briata P., Garcia-Mayoral M., Haase A.D., Filipowicz W., Ramos A., Gherzi R., Rosenfeld M.G. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Nature 2009, 459:1010-1014.
42. Wan G., Zhang X., Langley R.R., Liu Y., Hu X., Han C., Peng G., Ellis L.M., Jones S.N., Lu X. DNA-damage-induced nuclear export of precursor microRNAs is regulated by the ATM-AKT pathway. Cell Rep. 2013, 3:2100-2112.
43. Wan G., Liu Y., Han C., Zhang X., Lu X. Noncoding RNAs in DNA repair and genome integrity. Antioxid. Redox Signal. 2014, 20:655-677.
44. Welker N.C., Maity T.S., Ye X., Aruscavage P.J., Krauchuk A.A., Liu Q., Bass B.L. Dicer's helicase domain discriminates dsRNA termini to promote an altered reaction mode. Mol. Cell 2011, 41:589-599.
45. Yang Y., Ahn Y.H., Gibbons D.L., Zang Y., Lin W., Thilaganathan N., Alvarez C.A., Moreira D.C., Creighton C.J., Gregory P.A., et al. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. J.Clin. Invest. 2011, 121:1373-1385.
46. Yang D., Sun Y., Hu L., Zheng H., Ji P., Pecot C.V., Zhao Y., Reynolds S., Cheng H., Rupaimoole R., et al. Integrated analyses identify a master microRNA regulatory network for the mesenchymal subtype in serous ovarian cancer. Cancer Cell 2013, 23:186-199.
47. Yoon J.H., Srikantan S., Gorospe M. MS2-TRAP (MS2-tagged RNA affinity purification): tagging RNA to identify associated miRNAs. Methods 2012, 58:81-87.
48. Zhang X., Lu X. Posttranscriptional regulation of miRNAs in the DNA damage response. RNA Biol. 2011, 8:960-963.
49. Zhang L., Huang J., Yang N., Greshock J., Megraw M.S., Giannakakis A., Liang S., Naylor T.L., Barchetti A., Ward M.R., et al. microRNAs exhibit high frequency genomic alterations in human cancer. Proc. Natl. Acad. Sci. USA 2006, 103:9136-9141.
50. Zhang X., Wan G., Berger F.G., He X., Lu X. The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol. Cell 2011, 41:371-383.